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Oppositional defiant disorder (ODD) is a frequent psychiatric
disorder seen in children and adolescents with attention-deficit-
hyperactivity disorder (ADHD). ODD is also a common ante-
cedent to both affective disorders and aggressive behaviors.
Although the heritability of ODD has been estimated to be
around 0.60, there has been little research into the molecular
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genetics of ODD. The present study examined the association
of irritable and defiant/vindictive dimensions and categorical
subtypes of ODD (based on latent class analyses) with previously
described specific polymorphisms (DRD4 exon3 VNTR,
5-HTTLPR, and seven OXTR SNPs) as well as with dopamine,
serotonin, andoxytocingenesandpathways ina clinical sampleof
children and adolescents with ADHD. In addition, we performed
a multivariate genome-wide association study (GWAS) of the
aforementioned ODD dimensions and subtypes. Apart from
adjusting the analyses for age and sex, we controlled for “parental
ability to copewith disruptive behavior.”None of the hypothesis-
driven analyses revealed a significant association with ODD
dimensions and subtypes. Inadequate parenting behavior was
significantly associated with all ODD dimensions and subtypes,
most strongly with defiant/vindictive behaviors. In addition, the
GWAS did not result in genome-wide significant findings but
bioinformatics and literature analyses revealed that the proteins
encodedby28of the53 top-rankedgenes functionally interact ina
molecular landscape centered around Beta-catenin signaling and
involved in the regulation of neurite outgrowth. Our findings
provide new insights into themolecular basis ofODDand inform
future genetic studies of oppositional behavior.
 2015 The Authors. American Journal of Medical Genetics Part B: Neuropsychi-
atric Genetics Published by Wiley Periodicals, Inc.
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INTRODUCTION
Oppositional defiant disorder (ODD) shows strong comorbidity
with attention-deficit-hyperactivity disorder (ADHD), conduct
disorder (CD), and mood disorders [Angold et al., 1999], in both
epidemiological and clinical samples. Todate, the etiological basis of
this comorbidity is unclear, although shared genetic influences
between these disorders have been postulated to play a role [Faraone
et al., 1991; Dick et al., 2005]. Research into ODD has gained
momentum due to its relation to later psychopathology such as
affective disorders [Copeland et al., 2009] and antisocial personality
disorder [Langbehn et al., 1998]. Youths with ADHD frequently
show severe impulse control problems and are at high risk for
developing ODD. A better understanding of the developmental
pathways from ADHD to ODD is crucial to prevent further anti-
sociality and psychopathology. However, there has been little re-
search on the genetics of ODD, perhaps, because this disorder has
been viewed primarily as the result of ineffective parenting [Frick
et al., 1992]. Nevertheless, the heritability of ODDhas been estimat-
ed to be around 0.60 [Nadder et al., 1998; Coolidge et al., 2000] and
ODD is familial among families of ADHD youth [Petty et al., 2009].
ADHD has been the focus of considerable genetic research. A
meta-analysis of candidate gene studies found several polymor-
phisms associated with childhood ADHD, including several
markers in the dopaminergic and serotonergic systems, and sug-
gested associations in CHRNA4 and SNAP25 [Gizer et al., 2009].
Genome-wide association studies (GWAS) of ADHD did not yet
reveal any significant association [Neale et al., 2010; Hinney et al.,
2011; Stergiakouli et al., 2012; Ebejer et al., 2013; Yang et al., 2013;
Sanchez-Mora et al., 2015; Zayats et al., 2015]. There is compara-
tively little work into the molecular genetics of oppositional and
disruptive behaviors in children and adolescents. A recent meta-
analysis showed a significant association of the short allele of the
polymorphic region (5-HTTLPR) in the promoter region of the
serotonin transporter gene 5-HTT/SLC6A4 with antisocial behav-
iors (including aggression) [Ficks and Waldman, 2014], although
evidence for this association is conflicting [Vassos et al., 2014]. The
short allele has been found to affect negatively the transcription rate
of the gene compared to the long allele [Heils et al., 1996],
putatively affecting the availability of serotonin in the synaptic
cleft and thus increasing the risk for aggressive behavior. Further
studies also support the role of dopamine genes in the development
of ODD and/or CD. The variable number tandem repeat poly-
morphism (VNTR) within exon 3 of the dopamine receptor D4
gene (DRD4) has been frequently investigated in psychiatric ge-
netic studies and the 7-repeat allele was found to lead to less
efficient dopamine binding and reduced receptor sensitivity. Sev-
eral studies found individuals with the 7-repeat allele to have an
increased risk for ODD and CD symptoms [Holmes et al., 2002;
DiLalla et al., 2009]. In accordance with the findings forDRD4 and
5-HTTLPR, high levels of dopamine and low levels of serotonin
were associated with aggression and irritability in humans [Ryding
et al., 2008; Duke et al., 2013]. Deregulation of oxytocin (OXT)
signaling—for example, as a consequence of genetic variability—
also predisposes an individual to antisocial and aggressive behav-
iors and disrupts prosocial behaviors [Malik et al., 2012]. Two
studies found that low levels of OXT are linked to aggressive
behaviors in adult males [Fetissov et al., 2006; Lee et al., 2009].
In genetic studies, single nucleotide polymorphisms (SNPs) within
the oxytocin receptor gene (OXTR) were associated with callous-
unemotional and aggressive behaviors in males and females [Malik
et al., 2012; Zai et al., 2012]. To date, sevenOXTR SNPs (rs1042778,
rs6770632, rs237885, rs4564970, rs1488467, rs53576, rs13316193)
have been found to be related to aggression, CU behaviors, and/or
behavior problems [Park et al., 2010; Campbell et al., 2011; Beitch-
man et al., 2012; Johansson et al., 2012a; Johansson et al., 2012b;
Malik et al., 2012]. Most of the molecular genetic studies of OXTR
have been limited by small sample sizes, though, and therefore
warrant replication.
The phenotypic heterogeneity of ODD complicates the identi-
fication of genetic involvement with the occurrence of the disorder.
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An increasing number of studies supports the need for discrimi-
nation of ODD irritable and defiant/vindictive dimensions in
community samples of preschoolers, school-aged children, and
adolescents [Stringaris and Goodman, 2009a,b; Ezpeleta et al.,
2012; Krieger et al., 2013] as well as in children and adolescents
referred for ADHDor autism [Aebi et al., 2010;Mandy et al., 2014],
which may inform genetic studies. Irritable mood has been sug-
gested to underlie the developmental link between ODD and later
affective disorders [Stringaris et al., 2009], and a defiant/vindictive
behavioral pattern of ODD is associated with CD and the presence
of callous unemotional (CU) traits [Kolko and Pardini, 2010] as
well as later criminal outcomes in adulthood [Aebi et al., 2013]. A
genetic link betweenODD irritable behavior and depression, on the
one hand, and between ODD defiant/vindictive aspects and delin-
quent behavior, on the other, was found in a UK twin sample
[Stringaris et al., 2012].
In this study, we aim to investigate the genetic underpinnings of
ODD using data from the International Multicentre ADHD Ge-
netics (IMAGE) study [M€uller et al., 2011a,b] including 750
subjects. We first defined conceptually meaningful dimensions/
subtypes of oppositionality in order to improve the power of our
analyses by reducing the known heterogeneity of the ODD pheno-
type [Burke, 2012]. We subsequently tested genetic variants in
dopamine, serotonin, and oxytocin signaling pathways for their
association with the two dimensions and the two categorical
subtypes. We first tested individual polymorphisms earlier found
related to such traits, that is, theDRD4VNTR 7-repeat allele, the 5-
HTTLPR short allele, and variants in the OXTR gene. In a second
step, gene-wide analysis for DRD4, 5-HTT, OXTR, and gene-set
analysis of the dopamine, serotonin, and oxytocin pathways was
performed to test their associationwith the two dimensions and the
two categorical subtypes. Besides adjusting the analyses for age and
sex, we also controlled for parental ability to cope with disruptive
behavior because parenting behavior has been identified as a major
source of ODD [e.g., Burke et al., 2008]. We also tested the
interaction between genetic polymorphisms and “parental ability
to cope with disruptive behavior” and ODD subtypes/dimensions.
In addition to the hypothesis-driven analyses, we aimed to generate
new hypotheses about genetic involvement in ODD. Because
genetic overlap as well as differences can be expected to exist
between the two dimensions and the two categoricalODD subtypes
[Dowell et al., 2010] and to maximize power of our analyses
[Galesloot et al., 2014], we used a multivariate genome-wide
association testing framework. Employing bioinformatics and
literature mining, we integrated top-ranked findings from the
GWAS into a landscape of proteins and molecules that regulate
biological signaling cascades, providing important new insights
into the genetic etiology of ODD.
MATERIALS AND METHODS
Sample
The present study is based on 750 probands from the International
Multicentre ADHD Genetics (IMAGE) study. Participants of the
IMAGE study were European Caucasians aged 5–17 years, who had
been recruited in 12 child and adolescent psychiatry clinics rep-
resenting eight countries: Belgium, Germany, Switzerland, Hol-
land, Ireland, Israel, Spain, and theUnited Kingdom. Approval was
obtained by the Institutional Review Board of SUNY Upstate
Medical University and from ethical review boards within each
country. A detailed description of the study design and assessment
procedures has been provided in previous publications [M€uller
et al., 2011a,b]. In short, entry criteria for probands were a clinical
diagnosis of ADHD based on DSM-IV criteria and access to one or
both biological parents and one or more full siblings for DNA
collection and clinical assessment. Exclusion criteria applying to
both probands and siblings included autism, epilepsy, IQ <70,
brain disorders, and any genetic or medical disorder associated
with externalizing behaviors that might mimic ADHD. The full
sample of the IMAGEproject amounts to 1,067 subjects. Out of this
sample with ADHD combined type, 774 subjects with full infor-
mation on ODD phenotypes and covariates (see below) were
included in the analyses. Genome-wide imputed genotypes (HAP-
MAP2) and variable number of tandem repeats (VNTR) were
available for 750 subjects. Attrition analyses showed that the 317
subjects, who were not included in the analyses, did not differ from
the participating 750 subjects in terms of sex (male sex 86.8% vs.
87.7%; x2¼ 0.20, df¼ 1, P¼ n.s.), age (10.94 vs. 10.67 years;
t¼ 1.43, df¼ 1,065, P¼ n.s.), and ODD diagnosis (69.0% vs.
64.1%; x2¼ 2.32, df¼ 1, P¼ n.s.).
Measures
The long form of the revised Conners parent rating scale (CPRS-R:
L) was used in the present study [Conners, 1997; Conners et al.,
1998]. Subtypes and dimensions of oppositionality were assessed
by use of the 10 items (0¼ not true, 1¼ little true, 2¼much true,
3¼ very much true) of the CPRS-R:L oppositional scale. In total,
four different phenotype (two dimensional and two categorical)
measures were included in the present study and tested for differ-
ences in the candidate-based and hypothesis-free analyses (see
below). The use of dimensional as well as categorical measures
of ODD is in line with previous research confirming (1) separate
but correlated dimensions of ODD [Stringaris and Goodman,
2009a,b; Aebi et al., 2010; Ezpeleta et al., 2012; Aebi et al., 2013;
Krieger et al., 2013] and (2) distinct subtypes of irritable and severe
forms of ODD [Burke, 2012; Kuny et al., 2013; Althoff et al., 2014].
(1) Two dimensions were defined on theoretical grounds, which
reflected the two previously described dimensions of ODD
[Stringaris et al., 2012; Aebi et al., 2013], namely defiant/
vindictive (P1) and irritable (P2). The items related to P1
with scores ranging from 0 to 18 and P2 with scores from 0 to
12 for P2 are shown in Figure 1. Internal consistencies (Cron-
bach alpha) amounted to 0.79 and 0.82 for the defiant/vindic-
tive and the irritable dimension, respectively. Because of a right
skewed distribution, a Blom transformation [Blom, 1958] of
P2 was performed.
(2) Two further dichotomous subtypes were based on findings
from a latent class analysis (LCA). LCA was performed using
poLCA package [Linzer and Jeffrey, 2011] in R statistic soft-
ware [R Development Core Team, 2011]. All of the 10 dichot-
omized CPRS-oppositionality items (0 and 1 were scored as
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absent; 2 and 3 were scored as present) were included in
analysis. One to five class models were compared, and the
Bayesian Information Criterion (BIC) and the Akaike Infor-
mation Criterion (AIC) were used to determine the number of
classes. The four class solution, which fitted the data best
(BIC¼ 11,169; AIC¼ 10,955), contained classes labeled low
oppositionality (OPP), moderate OPP, irritable OPP, and severe
OPP (see Fig. 1). Because of our interest in severe forms of
ODD, we defined the following dichotomous phenotypes: a
dichotomous subtype P3, with 0 representing “low OPP/
moderate OPP” (n¼ 331) and 1 representing “irritable
OPP/severe OPP” (n¼ 419), and a dichotomous subtype
P4, with 0 representing “low OPP/moderate OPP/irritable
OPP” (n¼ 534) and 1 representing “severe OPP” (n¼ 216).
The DSM-IV diagnoses of ODD/CD and parental ability to cope
with disruptive behaviors was coded from the diagnostic interview
(parental account of childhood symptoms [PACS]; Chen and
Taylor, 2006; Taylor et al., 1986] A parent (usually the mother)
responded to a 7-point Likert-scale ranging from 0 (efficient
coping) to 7 (abusive parental behavior) measuring maternal
and paternal coping with disruptive behaviors. A mean score
was used when information for both parents was available. Fur-
thermore, the oppositional scale of the Conners’ teacher rating
scale (CTRS- R:L; [Conners, 1997]) and the conduct problem
scale of the Strengths and Difficulties Questionnaire [Goodman,
1997] were used for phenotype description.
DNA Collection and Genotype Assays
Sample collection andDNA isolation has been described previously
[Brookes et al., 2006]. Genome-wide genotyping and data cleaning
was performed as part of the GAIN study using the Perlegen 600K
genotyping platform, as described in Neale et al. [2008]. To
increase genomic coverage, imputation was performed using
MACH and the Hapmap 2 (Release 22 Build 36) reference data
set [Y. Li et al., 2010]. Quality control was performed on the
imputed data, and SNPs with imputation quality scores lower than
0.30, a minor allele frequency lower than 0.01, and those failing
the Hardy–Weinberg equilibrium test at a threshold of P 105
were excluded. In addition, SNPs and subjects with missingness
rates higher than 0.05 were removed from the data. Distributed
over 22 autosomes, 1,871,025 SNPs were left for analysis.
Genotyping of candidate polymorphisms (DRD4 exon 3 VNTR;
5-HTTLPR) was performed at the SGDP laboratories in London
or at the Human Genetics department of the Radboudumc
in Nijmegen, the Netherlands. Standard PCR protocols were
used, as previously described [Brookes et al., 2006; Thissen
et al., 2015].
Statistical Analyses
Analysis of candidate polymorphisms. For the oxytocin re-
ceptor gene OXTR, only one of the seven SNPs previously linked
with aggression was present in the data (rs1488467). Linear and
logistic regression analyses were used to test the effects of theDRD4
exon 3 variant (presence/absence of the 7-repeat allele: 7R/7R and
7R/other vs. other/other), the 5-HTT variant (presence/absence of
the 5-HTTLPR short allele: S/S and S/L vs. L/L), and the OXTR
rs1488467 SNP (presence/absence of C: C/C and C/G vs. G/G) on
the ODD dimensions/subtypes. Variables included in the model
were age, sex, and parental ability to cope with disruptive behav-
iors, as well as the interaction of DRD4, 5-HTTLPR, and OXTR
rs1488467 genotype with parental ability to cope with disruptive
behaviors. In addition, since only one of the seven OXTR SNPs of
interest was present in the data, outcome of the association analysis
FIG. 1. Mean scores of dichotomized items of the Conners parent scale (CPRS-R:L) oppositional scale assessing irritable (IRR1-IRR4), and
defiant/vindictive (DV1–DV6) behaviors as a function of latent classes for children and adolescents with ADHD combined type (N¼ 750). OPP,
oppositionality.
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of all SNPs located in that region was plotted to find out if an
association signal was presented by closely related linked SNPs.
Gene-wide and gene-set analyses. Gene-wide analysis was
applied for 5-HTT as well as for DRD4 and OXTR using a
mass-univariate approach, to take potential allelic heterogeneity
into account and test if a combination of SNPs located in these
genes showed association with the ODD dimensions/subtypes.
Similarly, gene-set analysis was performed for all genes involved
in serotonin, dopamine, and oxytocin neurotransmission. A list of
genes included in each pathway-wide analysis can be found in
Supplementary Table SI. All available variants of each gene were
extracted, including variants within a 100 kilobase (kb) flanking
region of each gene to capture regulatory sequences. The effect of
common variants of each gene or gene-set of interest on the two
dimensions and the two categorical subtypeswas investigated using
the statistical approach described by Bralten et al. [2013] consisting
of SNP-by-SNP regression and estimation of the effect of the whole
gene or gene-set. For both gene-wide and gene-set based analyses,
linkage disequilibrium-pruned genotyping data were prepared,
using the “indep” command in Plink [Purcell et al., 2007] with
a r2 threshold of 0.8.
Correction for multiple testing. Results were considered to
be significant if they reached the Bonferroni corrected P-value
threshold for multiple testing (0.05 divided by the number of
phenotypes, polymorphisms, and gene(-sets) tested; P-value
threshold¼ 1.4E-3).
Multivariate genome-wide association study. We performed
a multivariate GWAS to capture covariance among the different
correlated ODD dimensions/subtypes and to increase the power
for finding genetic associations. Using only a single test for
association instead of four has the additional advantage of a
reduced multiple testing burden. Following analysis of correlation
between traits, we assessed association between genetic markers
and the two dimensions and the two categorical subtypes using the
MQFAM multivariate extension of PLINK [Ferreira and Purcell,
2009]. Residuals obtained for each subtype after adjustment for
age, sex, parental ability to cope with disruptive behavior, and four
population components derived from multidimensional scaling
analysis were used as input. The MQFAM method uses canonical
correlation analysis to identify the linear combination of traits that
maximizes the covariance between amarker and the traits. It can be
used for analysis of a combination of quantitative and binary traits
[Ferreira and Purcell, 2009; Galesloot et al., 2014]. For each SNP
included in the analysis, a loading is calculated in the output which
reflects the contribution of each phenotype to the association
results. Top-SNPs (P< 1.00E-5) from the multivariate GWAS
were investigated for their location in or around genes and for
their performance in univariate analysis, which provided informa-
tion on the direction of effect.
Molecular landscape building: bioinformatics and literature
analyses. To increase the understanding of the molecular basis of
ODD, we aimed at integrating the top findings from the GWAS
into a landscape of functionally interacting proteins andmolecules
that regulate biological signaling cascades. First, a list of indepen-
dent association regionswas obtained by clumping the results using
PLINK [Purcell et al., 2007]. SNPs in LD (r2 0.2) within 10,000 kb
of a more significant index SNP were discarded. Second, a thresh-
old of P< 1.00E-04 was applied for index SNPs, resulting in
65 LD-independent regions. The chosen statistical cut-off for
association of P< 1.00E-04 is often used to designate ‘suggestive’
association and has been previously used in studies of neuro-
developmental disorders (ADHD and autism) [Poelmans et al.,
2011b, 2013]. Third, a list of top genes was compiled. Gene
annotation was performed when an index SNP was located within
an exon, an intron, or untranslated region of the gene, or when an
index SNP was located within a region 100 kb downstream or
upstream of the gene to capture regulatory sequences [Veyrieras
et al., 2008; Gherman et al., 2009; Nicolae et al., 2010; Pickrell
et al., 2010].
We then conducted a canonical pathway analysis of the list of
top-ranked genes from the multivariate GWAS, using the Ingenui-
ty software package (http://www.ingenuity.com). For this pathway
enrichment analysis, Ingenuity draws on the Ingenuity Knowledge
Base which is based on information from published literature as
well as on various other sources including gene expression and gene
annotation databases. An enrichment P-value is calculated for each
pathway with the right-tailed Fisher’s exact test and correction for
multiple testing is performed using the Benjamini–Hochberg
correction. Subsequently, we searched the literature for the func-
tion of the proteins encoded by all the top-ranked genes from the
multivariate GWAS, using UniProtKb (http://www.uniprot.org/
uniprot) and Pubmed (http://www.ncbi.nlm.nih.gov/). The land-
scape building approach described here has been used in earlier
studies of neurodevelopmental disorders [Poelmans et al., 2011a,b,
2013] Lastly, the genes from the list with top findings were
investigated for previous implication in the etiology of neuro-
developmental or neuropsychiatric disorders using Ensembl re-
lease 75 [Flicek et al., 2014] and the NCBI databases (http://www.
ncbi.nlm.nih.gov/).
RESULTS
Descriptives
The final sample (N¼ 750) consisted of 658 boys (87.7%) and 92
girls (12.3%) aged 5–18 years (mean¼ 10.67 years, SD¼ 2.77).
According to the PACS interview, 481 (64.1%) children and
adolescents fulfilled DSM-IV criteria for ODD and 170 (22.7%)
for CD. Bivariate correlations of the two dimensions and the two
categorical subtypes are shown in Supplementary Table SII. All
correlations were significant and moderate. Furthermore, all
dimensions/subtypes were slightly correlated to teacher ratings
of oppositionality (CTRS), and moderately correlated to SDQ
conduct problems and DSM-IV diagnosis of ODD / CD (also
shown in Supplementary Table SII).
Candidate Polymorphisms
No associations of DRD4, 5-HTTLPR, and OXTR rs1488467 were
observed for any of the four measures, nor were any interactions of
parental ability to cope with disruptive behaviors with these
genotypes observed (Table I). Parental ability to cope with the
child’s disruptive behaviors was significantly associated with all
four ODD measures (except for 5-HTTLPR analysis of severe
oppositionality (P4)). Agewas positively associatedwith irritability
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(P2) and irritable/severe oppositionality (P3), in all three models.
There appeared to be no SNPs closely located to, and in high linkage
disequilibrium with, OXTR SNP rs1488467 that show association
with the ODD dimensions/subtypes (Supplementary Fig. S1).
Gene-Wide and Gene-Set analyses
Findings for the 5-HTT, DRD4, and OXTR genes and the neuro-
transmission pathways are shown in Table II. None of the analyses
revealed a significant association with any of the four ODD
phenotypes.
Multivariate Genome-Wide Association Study
As expected given the modest sample size (n¼ 750), multivariate
GWAS did not result in genome-wide significant findings
(P< 5.0E-08; [Dudbridge and Gusnanto, 2008]) (see Fig. 2,
and Supplementary Fig. S2 for the Quantile–Quantile plot).
Supplementary Table SIII presents the 53 SNPs showing associa-
tion with the ODD dimensions and subtypes at P< 1.00E-5,
together with their respective loadings reflecting the contribution
of each phenotype to the association results and their perfor-
mance in univariate analysis. The top three findings were for
rs7204436 (P¼ 1.98E-07) located in an intergenic region on
chromosome 16, rs1278352 (P¼ 1.24E-06) located in an intronic
region of the ADAM12 gene on chromosome 10, and rs12370275
(P¼ 2.41E-06) located in an intergenic region on chromosome
12 (Fig. 2). Also of interest is a region on chromosome 20 with a
large number of SNPs in high LD showing a strong association
signal. This region is located on chromosome 20q11.21 and is
spanning several genes (COX4I2, BCL2L1, TPX2, MYLK2,
FOXS1, TTLL9) (also depicted in Fig. 2).
Molecular Landscape Building
Using the criteria as described in the methods section, gene
annotation was performed for 44 out of 65 independent SNPs
with a P< 1.00E-04, resulting in a list of 53 top-ranked genes
(Supplementary Table SIV). The bioinformatics analysis with
Ingenuity revealed significant enrichment of the canonical path-
ways “Inhibition of matrix metalloproteases” (Pcorrected¼
1.19E-2), “Axonal guidance signaling” (Pcorrected¼ 2.60E-02),
and “Wnt/Beta-catenin signaling” (Pcorrected¼ 2.60E-02), with
the proteins encoded by nine of the top-ranked genes belonging
to one or more of these pathways (Table III). Importantly, all
proteins encoded by these nine genes play a role in neurite
outgrowth. In addition, the subsequent literature analysis revealed
that in total, 28 of the 53 top-rankedODDgenes (53%) interact in a
molecular landscape centered around b-catenin signaling and
involved in regulating neurite outgrowth (depicted in Fig. 3).
TABLE I. Linear and Logistic Regressions of the DRD4 Genotype (Presence/Absence of the Seven Repeat Allele: 7R7R and 7R/Other Vs.
Other/Other), of the HTTLPR Genotype (Presence/Absence of the Short Allele: S/S and S/L Vs. L/L), and of the OXTR Genotype
rs1488467 (Presence/Absence of C: C/C and C/G Vs. G/G) Predicting the Four Phenotypes of ODD
Phenotypes P1 P2 (transformed) P3 P4
Variables B B B B
DRD4 genotype
DRD4 (7R7R and 7R/other vs. other/other) 0.39 n.s. 0.08 n.s. 0.00 n.s. 0.10 n.s.
Parent coping (centered) 0.65

0.16

0.28

0.27

DRD4 (7R7R and 7R/other vs. other/other) parent coping (centered) 0.02 n.s. 0.08 n.s. 0.10 n.s. 0.12 n.s.
Sex (0¼ female, 1¼male) 0.69 n.s. 0.19 n.s. 0.33 n.s. 0.35 n.s.
Age 0.09 n.s. 0.04

0.07

0.05 n.s.
HTTLPR genotype
5-HTTLPR (S/S and S/L vs. L/L) 0.51 n.s. 0.02 n.s. 0.03 n.s. 0.20 n.s.
Parent coping (centered) 0.73

0.16

0.25

0.23 n.s.
5-HTTLPR (S/S and S/L vs. L/L) parent coping (centered) 0.13 n.s. 0.04 n.s. 0.00 n.s. 0.02 n.s.
Sex (0¼ female, 1¼male) 0.64 n.s. 0.19 n.s. 0.34 n.s. 0.28 n.s.
Age 0.08 n.s. 0.04

0.07

0.04 n.s.
OXTR rs1488467 genotype
rs1488467 (C/C and C/G vs. G/G) 0.14 n.s. 0.12 n.s. 0.13 n.s. 0.08 n.s.
Parent coping (centered) 0.63

0.13

0.25

0.24

rs1488467 (C/C and C/G vs. G/G) parent coping (centered) 0.35 n.s. 0.10 n.s. 0.11 n.s. 0.02 n.s.
Sex (0¼ female, 1¼male) 0.73 n.s. 0.22 0.35 n.s. 0.31 n.s.
Age 0.08 n.s. 0.03

0.06

0.04 n.s.
Note: P1, defiant vindictive dimension; P2, irritable dimension; P3, irritable/severe oppositionality; P4, severe oppositionality.

Significance (two sided), P< 0.05

Significance (two sided), P< 0.01

Significance (two sided), P< .001.
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This landscape encompasses signaling cascades that are important
for the neural modulations necessary for the growth of axons in
a specific direction. The evidence linking the molecules in the
landscape to neurite outgrowth is described in detail in the
Supplementary Information.
Fifteen of the top-ranked genes have also been implicated
previously in the etiology of neurodevelopmental and/or neuro-
psychiatric disorders. A summary of these genes and previous
findings from literature can be found in Supplementary Table SV.
DISCUSSION
The aim of this study was to reduce the known heterogeneity in
the ODD phenotype in order to improve the power to detect the
genetic underpinnings.We first identified four conceptuallymean-
ingful subtypes and dimensions of oppositionality in the IMAGE
sample. We then tested specific polymorphisms and genes/gene-
sets that have been previously implicated in aggression/disruptive
behavior for their effect on the two dimensions and the two
categorical subtypes. In addition to these hypothesis-driven analy-
ses, we aimed to generate new hypotheses about genetic involve-
ment in ODD by performing multivariate GWAS. By using
bioinformatics analysis and literature mining, we found that top
findings obtained from the GWAS fit into a neurite outgrowth-
regulating molecular landscape.
Previous research has focused on various dimensions within
oppositional defiant behaviors [Stringaris and Goodman, 2009b;
Aebi et al., 2010]. Further studies have attempted to identify
discrete classes of children and adolescents according to their
oppositional behavior profiles. Consistent with previous research
[Kuny et al., 2013; Althoff et al., 2014], LCA in the present study
revealed a low symptom endorsement type, an irritable type, and a
severe type with elevated scores on all symptoms. In contrast to
these previous findings, we additionally found a moderate opposi-
tional type with intermediate scores on all symptoms, but not a
specific defiant/vindictive type. Considering the large sample size
and the multi-site data collection for the sample of the present
study [M€uller et al., 2011a,b] one may conclude that, most proba-
bly, children with ADHD more often show the full range of ODD
symptoms rather than defiant/vindictive symptoms only. In con-
trast, irritability symptoms are frequently co-occurring in ADHD
children andmay represent a specific subtype of ADHD[Fernandez
de la Cruz et al., 2015].
Although we tried to reduce the heterogeneity of ODD by
identifying conceptually meaningful subtypes and dimensions of
oppositionality, we did not observe any significant associations or
interactions with previously postulated candidates (SNPs, genes,
andpathways). This is not surprising in light of inconsistent reports
of DRD4, 5-HTT, and OXTR effects on externalizing behaviors
(e.g., [Kirley et al., 2004; Beitchman et al., 2012; Malik et al., 2012;
Lavigne et al., 2013]), and the small effect sizes of most genetic risk
factors for behavioral measures. A recent meta-analysis did not
confirm a relation of DRD4 exon3 and 5-HTTLPR to aggression
and violence [Vassos et al., 2014]. Furthermore, our findings
mirror those of a previous study that did not find a DRD4/5-
HTTLPR- interactionwith parental support forODD in 4-year-old
children [Lavigne et al., 2013]. Parenting behavior was moderately
to strongly associated with the defined ODD dimensions and
subtypes. In line with behavioral theories on negative parent-child
interactions (e.g., coercive behaviors; [Patterson, 1982]), parenting
behavior was most strongly associated with defiant/vindictive
behaviors. Since parental ability to cope with the child’s disruptive
behavior was rated by PACS interviewers, and symptoms of
oppositionality were rated by parents, confounding of these var-
iables by rater-effects is unlikely.
In order to obtain new insights into genetic risk factors for ODD
that can inform future investigations of the neurobiology related to
oppositional behavior, we also conducted a multivariate GWAS
using the four ODD subtypes and dimensions. We found 53
markers that showed association with at least one of the four
phenotypes at P< 1.00E-5. The strongest association with opposi-
tional behavior was found for rs7204436 (P¼ 1.98E-07) located in
an intergenic region on chromosome 16. Although no genes are
located nearby, a novel microRNA was found 30 kb from the
marker which might regulate genes involved in the etiology of
oppositional behavior.
Out of 53markers with P< 1.00E-05, 46 were located in a region
on chromosome 20q11.21 spanning the genes COX4I2, BCL2L1,
TPX2, MYLK2, FOXS1, and TTLL9. It can be hypothesized that of
these genes, BCL2L1 is the most likely candidate causing suggestive
TABLE II. P-Values of Gene-Wide and Gene-Set-Based Analysis of 5-HTT, DRD4, and OXTR Genes and the Neurotransmission Pathways
for Serotonin, Dopamine, and Oxytocin
Gene-wide analysis Gene-set analysis
Phenotype
5-HTT
(20 SNPs)
DRD4
(14 SNPs)
OXTR
(71 SNPs)
Serotonin
(942 SNPs)
Dopamine
(2568 SNPs)
Oxytocin
(360 SNPs)
P1 0.2508 0.2756 0.3101 0.3458 0.5612 0.6798
P2 0.6463 0.9455 0.5737 0.5493 0.4726 0.9272
P3 0.9445 0.3128 0.9649 0.515 0.276 0.9991
P4 0.1632 0.7257 0.5579 0.5012 0.274 0.9377
Note: P1, defiant vindictive dimension; P2, irritable dimension; P3, irritable/severe oppositionality; P4, severe oppositionality.
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association of the region with oppositional behavior. The long
isoform Bcl-S(L) is an anti-apoptotic regulator expressed at high
levels in both the developing and the adult brain [Krajewska et al.,
2002]. Interestingly, it regulates neurotransmitter release and
retrieval of vesicles in neurons, thereby influencing presynaptic
plasticity [Li et al., 2013]. Recently, it has also been shown that
BCL2L1 is associated with volume of the putamen in a GWAS of
subcortical volumes in 30,717 individuals from 50 cohorts [Hibar
et al., 2015]. BCL2L1 is not present in our top gene list because of
filtering during the clumping procedure.
FIG. 2. Top: Manhattan plot of multivariate GWAS including ODD subtypes P1 (defiant vindictive), P2 (irritable), P3 (0 representing “low OPP/
moderate OPP” and 1 representing “irritability/severe OPP”), and P4 (0 representing “low OPP/moderate OPP/irritability” and 1 representing
“severe OPP”). Bottom: Top four regions (indicated by arrows in the manhattan plot) containing SNPs showing association at P< 1.00E-5 in
the multivariate GWAS. Top SNPs for each region are depicted in purple; rs7204436 on chromosome 16 (P¼ 1.98E-07), rs1278352 on
chromosome 10 (P¼ 1.24E-06), rs12370275 on chromosome 12 (P¼ 2.41E-06), and rs6060960 on chromosome 20 (P¼ 3.00E-06). OPP,
oppositionality.
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Genome-wide studies of aggression phenotypes are starting to
emerge. A GWAS of CD had been performed before in the current
ADHD sample [Anney et al., 2008], where one of the three
phenotypes used was defined as the sum score for 12 CPRS-R:L
items, giving perhaps a better representation of ODD than CD. In
contrast, we assumed in the present study that combining biologi-
cally valid and less heterogeneous subtypes of ODD through a
multivariate approach would improve power to define new hy-
potheses about the genetics of ODD. The top SNPs reported by
Anney et al. [2008], who performed family-based transmission
disequilibrium tests (TDT), did not reach suggestive significance
(P< 1.00E-04) in our study (Supplementary Table SVI). A few
other GWAS of aggression-related phenotypes have been reported
to date. We compared our association results for the oppositional
phenotypes to the top results of four published aggression related
genome-wide association studies [Alliey-Rodriguez et al., 2011;
Dick et al., 2011; Tielbeek et al., 2012;Mick et al., 2014]. None of the
SNPs in a 100 kb region surrounding these reported top results
reached the threshold for suggestive association in our study
(P< 1.00E-4) (Supplementary Fig. S3). Interestingly though
among our list of top genes is EPDR1 (ependymin related 1).
Ependymin is involved in control of aggressive behavior in fish,
where it is a neurotrophic factor that plays a role in neuronal
regeneration and adhesion [Sneddon et al., 2011]. Themammalian
ependymin related protein 1 shows significant sequence similarity
to piscine ependymins and has been proposed to be the human
homolog of the piscine ependymin [Nimmrich et al., 2001]. These
findings make EPDR1 an interesting candidate gene for future
investigations of genetic contributions to aggression phenotypes.
An additional comparison of SNPs reaching suggestive association
in our study (P< 1.00E-4) with a list of ADHDGWAS top hits with
P-value <1.00E-05 (Supplementary Table SVII, adapted from
Zayats et al. [2015]), did not reveal overlap of our findings with
top hits from genome-wide studies of ADHD phenotypes.
As could be expected based on sample size, our multivariate
approach did not retrieve any region that yielded genome wide
significant association with ODD. Nevertheless, using the de-
scribed landscape building approach, we have integrated the
top-ranked findings of the GWAS into a molecular landscape
involved in regulating neurite outgrowth. More than half of
our top-ranked ODD genes were found to interact functionally
within this landscape, identifying neurite outgrowth as a biological
process that is important for the etiology of ODD. This is in line
with neuroimaging studies indicating that aggressive behavior is
associated with dysfunctional brain circuitry involved in emotion
regulation and decision making [Blair, 2013]. Moreover, current
models of aggression postulate an impaired structural and func-
tional connectivity between prefrontal areas and subcortical struc-
tures such as the amygdala [Rusch et al., 2007; Siever, 2008; Saxena
et al., 2012]. Indeed, alterations in the efficiency or direction of
neurite outgrowth may underlie these dysfunctions.
The identifiedmolecular landscape centers around Beta-catenin
(CTNNB) signaling. CTNNB has a pivotal function in an impor-
tant signaling cascade leading to neurite outgrowth. The process of
neurite outgrowth can be initiated at the neuronal cell membrane,
where the binding of ligands from the extracellular matrix to their
receptors leads to the modulation of downstream molecular cas-
cades in the cytoplasm, cytoskeleton, and nucleus that are involved
in regulating neurite outgrowth. Importantly, several proteins
and signaling molecules in the landscape (highlighted in yellow
in Fig. 3)—including serotonin, testosterone, triiodothyronine,
growth hormone, and retinoic acid—have been associated with
ODD or aggressive behavior through genetic or functional evi-
dence (Supplementary Table SVIII). Starting with the findings on
genetic deficits in the metabolism of neurotransmitters in aggres-
sive patients [e.g., Valzelli, 1981] and the discovery of a nonsense
mutation in the MAOA gene leading to a syndrome characterized
by violent behavior [Brunner et al., 1993], the key role of mono-
amines and especially serotonin in aggression has been demon-
strated in a wide variety of human and animal studies [Anholt and
Mackay, 2012]. Several studies also show a correlation of levels of
the male hormone testosterone and aggression [Pavlov et al.,
2012] and it has been proposed that an altered testosterone-to-
cortisol ratiomay be associated with aggression in humans [Haller,
2012; Montoya et al., 2012]. Further, thyroid hormones are asso-
ciated with stress, and elevated levels of the active thyroid hormone
triiodothyronine (T3) are associated with conduct disorder and
criminal behavior [Ramklint et al., 2001; Stalenheim, 2004]. In
addition, several animal studies suggest that growth hormone
(GH) influences aggressive behavior. For example, GHRH
knock-out mice with GH deficiency show reduced aggressive
behavior which can be normalized by GH replacement [Sagazio
et al., 2011]. Lastly, chronic administration of synthetic retinoic
acid to rats reduced aggression- and increased flight-related
TABLE III. Three Canonical Pathways That Were Significantly Enriched in the Top 53 ODD GWAS Genes, Using Ingenuity Pathway
Analysis (www.ingenuity.com)
Canonical pathway Genes Significance

Adjusted significance

Inhibition of matrix metalloproteases ADAM10, ADAM12, MMP7 1.20E-04 1.19E-02
Axonal guidance signaling ABLIM2, ADAM10, ADAM12, MMP7, PAK7, SLIT1 6.46E-04 2.60E-02
Wnt/b-catenin signaling MMP7, RARB, SFRP4, SOX5 7.86E-04 2.60E-02
The genes encoding proteins that could be directly placed in the odd landscape are indicated in bold

Single test P-value calculated with the right-tailed Fisher’s exact test and taking into consideration both the total number ofmolecules from the analysed dataset and the total number ofmolecules that is
linked to the same gene category according to the Ingenuity Knowledge Base.

Multiple test-corrected P-values using the Benjamini–Hochberg correction (P< 0.05).
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behaviors in the resident-intruder paradigm [Trent et al., 2009].
The fact that these and other molecules active within our landscape
have been associated previously with aggressive behavior provides
corroborating evidence for the involvement of neurite outgrowth
in aggression etiology.
Of note, alterations in neurite outgrowth are not specific to the
etiology of ODD, as neurite outgrowth has also been shown to play
a role in the pathogenesis of other neurodevelopmental disorders
such as ADHD, autism spectrum disorders (ASD), dyslexia, and
schizophrenia [Penzes et al., 2011; Poelmans et al., 2011a,b, 2013].
It has been hypothesized in these studies that each of these disorders
may in part be explained by different functional consequences and
different primarily affected brain regions of disturbed neurite
outgrowth. Psychiatric disorders, including ODD, are currently
FIG. 3. Neurite outgrowth-regulating molecular landscape implicated in ODD. The evidence linking the molecules in the landscape to neurite
outgrowth can be found in the Supplementary Information.
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classified based on clinical presentation rather than underlying
etiology.Hence, shared genetic etiology can be expected to exist not
only between definable subtypes of psychiatric disorders, but also
between different psychiatric disorders as currently classified in
clinical practice. This notion is also supported by a recent study
[Cross-Disorder Group of the Psychiatric Genomics et al., 2013)
that detected substantial genetic correlations between five major
psychiatric disorders and by the fact that 15 out of the 53 top ranked
genes of our study have previously been associated with neuropsy-
chiatric and neurodevelopmental disorders.
This study is based on a representative clinical sample from eight
European countries. Psychometrically reliable and valid measures
and methods (e.g., LCA) were used for phenotype definitions and
advanced methods were performed in gene-set and genome-wide
analyses. However, the present study is limited to data obtained
from children and adolescents with ADHD combined type (which
is often comorbid with ODD) and although our findings may not
be generalized to other clinical and community samples, the
overlap of our top findings with results in other genetic studies
of psychiatric disorders suggests a broader validity. Our results
were based on Caucasian subjects only and the sample consisted
mostly of male subjects. Due to missing information in the PACS
and other instruments, our sample was reduced to 750 probands.
However, attrition analyses did not show significant differences
between probands included in the sample and drop-outs.
A potential source of bias in our bioinformatics analysis arises
from the fact that brain-expressed genes are relatively large. There-
fore, brain-expressed genes may be over-represented in our GWAS
results. If large genes are more likely found to be associated by
chance (because they containmore SNPs), this should be the case in
GWASs of both psychiatric disorders and non-psychiatric disor-
ders that do not originate in the brain. However, previous studies
have compared enrichment results for psychiatric disorders with
results fromCrohn’s disease and diabetes mellitus [Poelmans et al.,
2011b, 2013] and showed that the “neurological disease” category
enriched in the psychiatric GWASs showed very little or no
enrichment in Crohn’s disease or diabetes. Combined with the
fact that 53% of our ODD top genes also fitted in the molecular
landscape for neurite outgrowth based on extensive literature
mining, we argue that although some genes in the landscape
may have been chance findings, most candidate genes from the
GWAS represent true findings contributing to our phenotype.
Future studies conducting pathway analyses using algorithms
that address potential confounders such as the large size of brain
genes will be of additional information [Holmans et al., 2009; Lee
et al., 2012].
In summary, the present findings confirmed the existence of
various subgroups of youths with different oppositional symptom
profiles. However, against our expectations the examined ODD
dimensions and subtypes were not associated with previously
described candidate genes and pathways. By employing a multi-
variate genome-wide association approach, we identified several
genetic susceptibility loci that may inform future theories on the
etiology of oppositional behavior. We also identified a biological
landscape of molecular signaling cascades involved in neurite
outgrowth providing new insights into the etiology of ODD. In
part, our findings may reflect shared genetic risk factors for
psychiatric disorders. We hope to encourage further investigations
toward a biologically informed classification of psychopathology.
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